Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-19

FDA Approved: SOOLANTRA — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

FDA approved a supplemental application for Soolantra (ivermectin) from Galderma Laboratories, L.P. This action updates the product labeling to reflect the appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soolantra (ivermectin)

Snippet

SUPPL AP for SOOLANTRA (IVERMECTIN)